Is Asasantin discontinued?
The Australian registered medicine ASASANTIN SR dipyridamole 200mg/aspirin 25mg sustained release capsule bottle AUST R 68051 sponsored by Boehringer Ingelheim Pty Ltd has been discontinued.
Is Asasantin available?
Asasantin SR capsules are available in bottles of 20*, 30*, 50*, 60 or 100* capsules.
What is the replacement for Asasantin?
PATIENTS will continue to have access to a PBS-subsidised dipyridamole and aspirin combination, with the discontinued Asasantin SR able to be substituted with Diasp SR from Arrotex.
Is Diasp sr the same as Asasantin?
Diasp SR has been ‘a’ flagged by the Pharmaceutical Benefits Scheme (PBS) as bioequivalent and interchangeable with Asasantin SR. As the largest supplier to the PBS by volume, Arrotex is committed to ensuring Australian patients have ongoing access to their medicines.
Why is dipyridamole being discontinued?
Boehringer Ingelheim Pharmaceuticals has announced the permanent discontinuation of Persantine (dipyridamole) tablets and its authorized generics. The decision to discontinue the product is business-related and not due to product safety or efficacy.
What is the alternative to dipyridamole?
Dipyridamole Alternatives Compared
| Dipyridamole | Aspirin | Warfarin |
|---|---|---|
| Yes (this medicine) | Yes (this medicine) | Yes (this medicine) |
| Dosage Form(s) Available | ||
| Intravenous solution Oral tablet | Oral delayed release tablet Oral tablet Oral tablet, chewable Rectal suppository | Oral tablet |
| Brand Names |
Why is dipyridamole discontinued?
Is dipyridamole still available?
Nevertheless, based on evidence from this study, dipyridamole is still officially licenced for use as an adjunct to oral anticoagulation for the prophylaxis of thromboembolism associated with prosthetic heart valves.
Is clopidogrel the same as dipyridamole?
Clopidogrel monotherapy is an alternate to aspirin plus dipyridamole, with a similar risk of bleeding [8, 41–44], while dipyridamole reduces the risk of recurrent stroke without excess bleeding [23]. No previous studies have evaluated the hemorrhagic complications of the clopidogrel–dipyridamole combination.